Veradigm | Les Charges D'Exploitation



Operating Expenses Changement Date
Alcidion AUD 18.74M 7.68M 2024-12
Ambu A/S DKK 1.33B 63M 2025-03
Amplifon EUR 526.35M 67.84M 2025-03
Cardinal Health USD 54.15B 567M 2025-03
Centene USD 45.09B 4.46B 2025-03
Charles River Laboratories USD 909.5M 260.74M 2025-03
Cigna USD 63.49B 144M 2025-03
Convatec Group 1B 518M 2024-12
CVS Health USD 91.21B 3.64B 2025-03
Diasorin 225M 4.31M 2024-09
Elevance Health USD 46.09B 1.6B 2025-03
General Electric USD 7.99B 732M 2025-03
Gulf Medical Proj AED 148.56M 5.46M 2025-03
Humana USD 30.1B 342M 2025-03
IQVIA Holdings USD 3.34B 5M 2025-03
Kora Saude BRL 499.2M 4.33M 2024-12
Laboratory Of America USD 3.01B 100.2M 2025-03
Maximus USD 1.21B 107.07M 2025-03
McKesson USD 89.23B 4.84B 2025-03
Med Life RON 702.94M 69.16M 2024-12
Molina Healthcare USD 10.71B 595M 2025-03
Omnicell USD 281.29M 13.2M 2025-03
Oriola-kd EUR 436.7M 12.5M 2024-12
Owens Minor USD 2.63B 327.22M 2025-03
Quest Diagnostics USD 2.31B 46M 2025-03
Rede D'or Sao Luiz BRL 10.77B 337.56M 2025-03
Siemens Healthineers EUR 5.07B 284M 2025-03
Sonova Holding CHF 1.55B 44.4M 2024-09
Supermax Corporation Bhd MYR 200.61M 104.8M 2024-12
UnitedHealth USD 100.47B 7.46B 2025-03
Veeva Systems USD 532.46M 14.61M 2025-01
Walgreens Boots Alliance USD 38.97B 4.82B 2025-05
Xerox USD 1.48B 110M 2025-03



Veradigm Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.